Enzeme Biosciences is a biotech subsidiary of Alkem.
It has announced a new manufacturing facility in the US with an investment of $70 million.
The decision also aligns with President Trump’s call asking pharma companies to boost local manufacturing and generating employment.
At present, Enzene has hired 50 people and aims to take a total of 200 on board over time.
“We nurtured and developed the technology of connected continuous manufacturing. Our EnzeneX (technology name) is now finding its home in the United States, the land of innovation,” Himanshu Gadgil, CEO, Enzene Biosciences.